Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Department of Justice
Federal Trade Commission
McKesson
Mallinckrodt
Teva
Deloitte
Merck
Fish and Richardson

Generated: December 14, 2018

DrugPatentWatch Database Preview

Twi Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for TWI PHARMS, and what generic and branded alternatives to TWI PHARMS drugs are available?

TWI PHARMS has fourteen approved drugs.



Summary for Twi Pharms
US Patents:0
Tradenames:14
Ingredients:14
NDAs:14

Drugs and US Patents for Twi Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Twi Pharms GUANFACINE HYDROCHLORIDE guanfacine hydrochloride TABLET, EXTENDED RELEASE;ORAL 201408-003 Jun 2, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Twi Pharms BENZPHETAMINE HYDROCHLORIDE benzphetamine hydrochloride TABLET;ORAL 040578-001 Apr 17, 2006 AA RX No No ➤ Sign Up ➤ Sign Up
Twi Pharms CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 206553-001 Nov 29, 2016 AA RX No No ➤ Sign Up ➤ Sign Up
Twi Pharms GUANFACINE HYDROCHLORIDE guanfacine hydrochloride TABLET, EXTENDED RELEASE;ORAL 201408-004 Jun 2, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Twi Pharms HYDROXYCHLOROQUINE SULFATE hydroxychloroquine sulfate TABLET;ORAL 210441-001 May 1, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Twi Pharms DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205231-003 Aug 30, 2018 AB3 RX No No ➤ Sign Up ➤ Sign Up
Twi Pharms DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205231-004 Aug 30, 2018 AB3 RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKesson
McKinsey
Teva
Dow
Express Scripts
Fuji
Chubb
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.